Understanding cell membrane changes in centronuclear myopathy and Charcot-Marie-Tooth disease
Dr Shevchuk and his team have established a method that allows them to study the effects of mutations in the […]
Continue Reading
Dr Shevchuk and his team have established a method that allows them to study the effects of mutations in the […]
Continue ReadingCHARCOT-MARIE-TOOTH is a neurological, incurable condition which can cause symptoms including uncontrollable pain and chronic fatigue. Charcot-Marie-Tooth (CMT) can also […]
Continue ReadingDuring September’s Charcot-Marie-Tooth Disease Awareness Month, we look at the symptoms of this inherited neurological condition. Have you ever heard […]
Continue ReadingA father has told of his heartbreak after his son inherited the same rare degenerative condition as him and is […]
Continue ReadingCharcot-Marie-Tooth disease (CMT) is a genetic neurological disorder that affects around 23,000 people in the UK but is little known. […]
Continue ReadingA mother who suffers from a disorder which makes feet shrink only managed to get a diagnosis after sharing symptoms […]
Continue Reading
A mum wants to raise awareness of a rare condition that saw her daughter in a wheelchair just nine months after she was diagnosed.
Continue Reading
Acceleron Pharma Inc, a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of innovative therapeutics
Continue ReadingResearch conducted at the Institute of Neurology of University College London (UCL) just published in the Proceedings of the National Academy of Sciences USA has identified a set of novel therapeutic targets for a subtype of Charcot-Marie-Tooth disease (CMT), a human condition that currently has no effective treatments.
Continue ReadingDr Andrew Shevchuk and his team from Imperial College London will investigate how mutations associated with some types of centronuclear myopathy and Charcot-Marie-Tooth disease (CMT)
Continue ReadingLast Updated: Monday 12th September, 2016